JIANGSU HENGRUI MEDICINE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 46.18 CNY | +1.25% |
|
+10.32% | +2.10% |
| 04-26 | Hengrui Pharma Gets Nod to Trial Insulin Aspart Injection; Shares Up 3% | MT |
| 04-17 | Jiangsu Hengrui Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
ETFs positioned on Jiangsu Hengrui Medicine Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 4.18% | 2 M€ | -14.86% | - | |
| 3.73% | 2 M€ | -14.14% | ||
| 1.74% | 1 M€ | -9.86% | - | |
| 1.18% | 96 M€ | -0.43% | ||
| 0.51% | 35 M€ | -5.85% | - | |
| 0.27% | 4 M€ | -11.56% | ||
| 0.15% | 11 M€ | +2.69% | ||
| 0.07% | 1 M€ | +3.49% | - | |
| 0.07% | 3 M€ | -.--% | - | |
| 0.03% | 441 M€ | +5.00% | - | |
| 0.03% | 2,808 M€ | +6.61% | - | |
| 0.03% | 149 M€ | +3.21% | - | |
| 0.03% | 117 M€ | +1.54% | - | |
| 0.03% | 4 M€ | -4.41% | - | |
| 0.01% | 31 M€ | +4.15% | - | |
| 0.00% | 7 M€ | +2.68% | - | |
| 0.00% | 34 M€ | +2.43% | - | |
| 0.00% | 389 M€ | +6.67% | - | |
| 0.00% | 34 M€ | +6.75% | - | |
| 0.00% | 147 M€ | +4.88% | - | |
| 0.00% | 39 M€ | +4.26% | - | |
| 0.00% | 302 M€ | +4.39% | - |
Jiangsu Hengrui Medicine Co., Ltd. specializes in the research, development, manufacture and marketing of pharmaceutical products. The activity is organized primarily around 5 families of products:
- anti-tumor drugs (No. 1 Chinese);
- Anesthetic drugs;
- contrast agents: used in medical imaging;
- anti-inflammatory drugs;
- drugs for the treatment of cardiovascular diseases.
Sector
Pharmaceuticals
Calendar
15/05/2024
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
46.18
CNY
Average target price
57.27
CNY
Spread / Average Target
+24.01%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +2.10% | 40.56B | |
| +26.47% | 664B | |
| +27.73% | 567B | |
| -6.33% | 354B | |
| +19.35% | 330B | |
| +4.23% | 286B | |
| +14.55% | 234B | |
| +5.02% | 199B | |
| -10.02% | 196B | |
| -4.04% | 148B |
- Stock Market
- Equities
- 600276 Stock
- Funds and ETFs Jiangsu Hengrui Medicine Co., Ltd.
